QQQ   280.47 (-1.50%)
AAPL   115.05 (+0.01%)
MSFT   210.08 (-2.84%)
FB   277.11 (-2.70%)
GOOGL   1,584.29 (-2.98%)
AMZN   3,207.04 (+0.08%)
TSLA   420.28 (-0.08%)
NVDA   525.65 (-3.30%)
BABA   306.87 (-0.98%)
CGC   18.53 (-6.08%)
GE   7.38 (-3.28%)
MU   52.14 (-1.34%)
AMD   82.23 (+0.33%)
T   27.38 (-1.58%)
F   8.03 (-1.59%)
ACB   4.40 (-5.98%)
GILD   59.96 (-1.37%)
NFLX   488.24 (+-0.01%)
NIO   26.01 (-4.23%)
BA   160.83 (-3.90%)
DIS   124.06 (-3.34%)
QQQ   280.47 (-1.50%)
AAPL   115.05 (+0.01%)
MSFT   210.08 (-2.84%)
FB   277.11 (-2.70%)
GOOGL   1,584.29 (-2.98%)
AMZN   3,207.04 (+0.08%)
TSLA   420.28 (-0.08%)
NVDA   525.65 (-3.30%)
BABA   306.87 (-0.98%)
CGC   18.53 (-6.08%)
GE   7.38 (-3.28%)
MU   52.14 (-1.34%)
AMD   82.23 (+0.33%)
T   27.38 (-1.58%)
F   8.03 (-1.59%)
ACB   4.40 (-5.98%)
GILD   59.96 (-1.37%)
NFLX   488.24 (+-0.01%)
NIO   26.01 (-4.23%)
BA   160.83 (-3.90%)
DIS   124.06 (-3.34%)
QQQ   280.47 (-1.50%)
AAPL   115.05 (+0.01%)
MSFT   210.08 (-2.84%)
FB   277.11 (-2.70%)
GOOGL   1,584.29 (-2.98%)
AMZN   3,207.04 (+0.08%)
TSLA   420.28 (-0.08%)
NVDA   525.65 (-3.30%)
BABA   306.87 (-0.98%)
CGC   18.53 (-6.08%)
GE   7.38 (-3.28%)
MU   52.14 (-1.34%)
AMD   82.23 (+0.33%)
T   27.38 (-1.58%)
F   8.03 (-1.59%)
ACB   4.40 (-5.98%)
GILD   59.96 (-1.37%)
NFLX   488.24 (+-0.01%)
NIO   26.01 (-4.23%)
BA   160.83 (-3.90%)
DIS   124.06 (-3.34%)
QQQ   280.47 (-1.50%)
AAPL   115.05 (+0.01%)
MSFT   210.08 (-2.84%)
FB   277.11 (-2.70%)
GOOGL   1,584.29 (-2.98%)
AMZN   3,207.04 (+0.08%)
TSLA   420.28 (-0.08%)
NVDA   525.65 (-3.30%)
BABA   306.87 (-0.98%)
CGC   18.53 (-6.08%)
GE   7.38 (-3.28%)
MU   52.14 (-1.34%)
AMD   82.23 (+0.33%)
T   27.38 (-1.58%)
F   8.03 (-1.59%)
ACB   4.40 (-5.98%)
GILD   59.96 (-1.37%)
NFLX   488.24 (+-0.01%)
NIO   26.01 (-4.23%)
BA   160.83 (-3.90%)
DIS   124.06 (-3.34%)
Log in
NYSEARCA:CHB

Global X China Biotech Innovation ETF Stock Forecast, Price & News

$15.48
+0.11 (+0.72 %)
(As of 10/26/2020 12:00 AM ET)
Add
Today's Range
$15.37
Now: $15.48
$15.59
50-Day Range N/A
52-Week Range
$15.16
Now: $15.48
$16.60
Volume1,662 shs
Average Volume2,668 shs
Market Capitalization$1.55 million
P/E RatioN/A
Dividend Yield0.00%
BetaN/A

Geographic Exposure of CHB

Currency Exposure of CHB

Sector Exposure of CHB

Industry Exposure of CHB

Basic Details

Issuer
Fund NameGlobal X China Biotech Innovation ETF
Tax Classification
SymbolNYSEARCA:CHB
Inception Date1/1/2100
Fund Manager
WebN/A
PhoneN/A

Fund Focus

Asset Class
Benchmark
Category
Focus
Development Level
Region

Fund Statistics

Assets Under Management$1.54 million
Average Daily Volume$0.00
Discount/Premium0.00%

ETF Expenses

Management Fee0.00%
Other Expenses0.00%
Total Expenses0.00%
Fee Waiver0.00%
Net Expenses0.00%

Administrator, Advisor and Custodian

Administrator
Advisor
Custodian
Distributor
Transfer Agent
Trustee
Lead Market Maker
$15.48
+0.11 (+0.72 %)
(As of 10/26/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CHB News and Ratings via Email

Sign-up to receive the latest news and ratings for CHB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Global X China Biotech Innovation ETF (NYSEARCA:CHB) Frequently Asked Questions

What is Global X China Biotech Innovation ETF's stock symbol?

Global X China Biotech Innovation ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "CHB."

How do I buy shares of Global X China Biotech Innovation ETF?

Shares of CHB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Global X China Biotech Innovation ETF's stock price today?

One share of CHB stock can currently be purchased for approximately $15.48.

How big of a company is Global X China Biotech Innovation ETF?

Global X China Biotech Innovation ETF has a market capitalization of $1.55 million.

This page was last updated on 10/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.